The stock of Arvinas Inc (ARVN) has gone down by -5.03% for the week, with a -15.97% drop in the past month and a -4.76% drop in the past quarter. The volatility ratio for the week is 3.22%, and the volatility levels for the past 30 days are 4.58% for ARVN. The simple moving average for the past 20 days is -9.21% for ARVN’s stock, with a 29.32% simple moving average for the past 200 days.
Is It Worth Investing in Arvinas Inc (NASDAQ: ARVN) Right Now?
Moreover, the 36-month beta value for ARVN is 1.90. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ARVN is 58.38M and currently, short sellers hold a 13.57% of that float. On April 04, 2024, ARVN’s average trading volume was 748.43K shares.
ARVN) stock’s latest price update
The stock of Arvinas Inc (NASDAQ: ARVN) has increased by 1.71 when compared to last closing price of 38.59. Despite this, the company has experienced a -5.03% fall in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-03-04 that NEW HAVEN, Conn., March 04, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in three upcoming investor conferences:
Analysts’ Opinion of ARVN
Many brokerage firms have already submitted their reports for ARVN stocks, with Oppenheimer repeating the rating for ARVN by listing it as a “Outperform.” The predicted price for ARVN in the upcoming period, according to Oppenheimer is $80 based on the research report published on February 28, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see ARVN reach a price target of $55, previously predicting the price at $36. The rating they have provided for ARVN stocks is “Neutral” according to the report published on February 14th, 2024.
Goldman gave a rating of “Buy” to ARVN, setting the target price at $70 in the report published on February 01st of the current year.
ARVN Trading at -12.35% from the 50-Day Moving Average
After a stumble in the market that brought ARVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.06% of loss for the given period.
Volatility was left at 4.58%, however, over the last 30 days, the volatility rate increased by 3.22%, as shares sank -15.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.61% upper at present.
During the last 5 trading sessions, ARVN fell by -6.16%, which changed the moving average for the period of 200-days by +32.74% in comparison to the 20-day moving average, which settled at $42.87. In addition, Arvinas Inc saw -4.64% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARVN starting from Houston John G, who sale 5,196 shares at the price of $47.05 back on Feb 23 ’24. After this action, Houston John G now owns 1,036,681 shares of Arvinas Inc, valued at $244,472 using the latest closing price.
Cassidy Sean A, the Chief Financial Officer of Arvinas Inc, sale 1,702 shares at $47.05 during a trade that took place back on Feb 23 ’24, which means that Cassidy Sean A is holding 181,916 shares at $80,079 based on the most recent closing price.
Stock Fundamentals for ARVN
Current profitability levels for the company are sitting at:
- -5.11 for the present operating margin
- 0.91 for the gross margin
The net margin for Arvinas Inc stands at -4.66. The total capital return value is set at -0.38. Equity return is now at value -59.97, with -28.55 for asset returns.
Based on Arvinas Inc (ARVN), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -119.93. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is 56.55.
Currently, EBITDA for the company is -394.8 million with net debt to EBITDA at 0.78. When we switch over and look at the enterprise to sales, we see a ratio of 30.0. The receivables turnover for the company is 10.9for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.98.
Conclusion
To wrap up, the performance of Arvinas Inc (ARVN) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
